Ju-Sheng Zheng

Principal Investigator

Westlake University
Country flagChina
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Background and Objectives: Recent large-scale studies have consistently linked healthy dietary patterns to improved cardiometabolic health; however, the underlying biological pathways remain largely unclear, especially in non-European populations. In this study, we leverage data from four population-based cohorts (UK Biobank, NEO study, GNHS, and 10K) to investigate both common and cohort-specific biological pathways linking healthy dietary patterns to cardiometabolic disease through multi-omics profiling. Material and methods: In each cohort, we first assessed the associations between each of the five major dietary pattern scores (i.e., AMED, hPDI, DII, AHEI, and EDIH) and cardiometabolic disease risk using Cox or logistic regression models. To explore the potential mediating role, metabolomics and proteomics measurements were incorporated into the models. All models were adjusted for relevant confounders, and false discovery rate correction was applied to account for multiple testing. Results: With a total of 71,679 individuals without pre-existing cardiometabolic disease across four participating cohorts (UKB: 54,024, NEO: 4,838, GNHS: 3,201, and 10K: 9,616), we confirmed that adherence to healthy dietary patterns was associated with a 5-10% reduced risk of cardiometabolic disease. Three common biological pathways were identified: (1) mediation via large HDL particles and apolipoprotein F; (2) mediation via DNAJ/Hsp40 and triglyceride-rich lipoproteins; and (3) mediation via CRHBP-regulated HPA axis activity affecting triglyceride-rich lipoproteins. Conclusions: Our integrative multi‐omics analysis across diverse populations identifies novel biomarkers that connect healthy dietary patterns with cardiometabolic risk. These findings deepen our understanding of the biological mechanisms underlying diet‐related disease and hold promise for enhancing the development of precision nutrition interventions.

Year:

2026

While the Human Microbiome Project (HMP) significantly advanced our understanding of the human microbiome, our revisiting of its fecal ITS2 sequencing data reveals two significant issues. First, technical variations in sequencing or data processing introduce batch effects in downstream analyses. Second, we discovered a mismatch between the reported and actual amplification primers, which requires careful consideration when interpreting, reusing, or referencing HMP ITS2 data and methodology.

Year:

2025

We aim to investigate the association of plant‐based diets with the continuous glucose monitoring (CGM)‐derived glycemic metrics among gestational diabetes mellitus (GDM) patients. We included 1756 GDM patients in the present analyses and assessed plant‐based dietary patterns through constructing a plant‐based diet index (PDI), healthy PDI (hPDI), and unhealthy PDI (uPDI). CGM‐glycemic metrics, such as time in range (TIR), mean blood glucose (MBG), time below range (TBR), low blood glucose index (LBGI), mean of daily differences (MODD), and glycemic risk assessment in diabetes equation (GRADE), were constructed. We found that individuals in the highest quartile of PDI were more likely to have greater TIR (β: 0.28, 95% CI: 0.14 to 0.41) and MBG (β: 0.23, 95% CI: 0.09 to 0.36), while lower TBR (β: −0.26, 95% CI: −0.39 to −0.12), LBGI (β: −0.18, 95% CI: −0.32 to −0.05), and GRADE (β: −0.25, 95% CI: −0.39 to −0.11), compared to those in the lowest quartile. Moreover, most of these associations demonstrated a dose‐response relationship, and hPDI and uPDI showed distinct associations with MODD, with higher hPDI favoring a healthier MODD pattern (FDR < 0.05). This study suggests potential benefits of increasing intake of plant‐based food for glycemic management among GDM patients.

Year:

2025

Evidence is insufficient to establish a longitudinal association between combined trajectories of body mass index (BMI) and waist circumference (WC) and dyslipidemia. This study investigated the associations between multi-trajectories of BMI and WC over 24 years and the subsequent risk of dyslipidemia in a large cohort of 10,678 Chinese adults from the China Health and Nutrition Survey. Utilizing a group-based trajectory model, we identified four distinct trajectories: normal, normal-increasing, overweight-increasing, and obesity-increasing. Our results indicated that ascending trajectories of BMI and WC are significantly associated with increased odds of dyslipidemia, particularly in males, with odds ratios (OR) of 2.10, 2.69, and 3.56 for the normal-increasing, overweight-increasing, and obesity-increasing groups, respectively. Among females, the normal-increasing group exhibited a significant increased risk (OR: 1.54). Furthermore, we explored the gut microbiota associated with these trajectories, identifying 3, 8, and 4 bacterial genera linked to increasing BMI and WC in males, alongside two genera in females with the normal-increasing trajectory. We identified a total of 23, 25, and 10 differential metabolites significantly associated with these genera, except for Group 2 in males. The inclusion of relevant microbiome and metabolite data improved the model’s predictive capacity for the risk of dyslipidemia, with ROC values increasing from 0.655 to 0.875. Our findings underscore the critical implications of continuous weight gain on metabolic health and suggest that gut microbiota may play a pivotal role in understanding these associations. IMPORTANCE Emerging evidence suggests a close connection between the gut microbiome and both human obesity and dyslipidemia, suggesting that the gut microbiome may play an important role in the obesity-dyslipidemia relationship. In this study, we observed several characteristic genera, including Clostridium_sensu_stricto_1 , Turicibacter , and CHKCI002 among males and Parabacteroides and [Eubacterium]_brachy_group among females, which were negatively associated with high-risk trajectories. They were also related to free fatty acids (FFAs) and oxidized lipid metabolites. These shared and unique gut microbial and metabolic signatures among combined trajectories of BMI and WC with a higher risk of dyslipidemia could provide important evidence for the omics mechanism pathway of long-term obesity trend leading to dyslipidemia.

Year:

2025

Cardiometabolic health is closely linked to diet. Both specific food choices and dietary indices are commonly used to guide cardiometabolic protection strategies. However, the balance between foods may also significantly impact cardiometabolic health. Here, we explore the balance and imbalance in long-term dietary food intake to quantify food pairing patterns (FPs), providing insights beyond conventional dietary indices and single-food intake frequencies. Using data from our GGMP (n = 6,994) and the NHANES (n = 7,350) cohorts, we observed that long-term food pairing patterns are independent of single food intake frequency and dietary indices. We identified 1,759 and 306 cardiometabolic-related long-term food pairing patterns from two cohorts (FDR < 0.05), respectively. Notably, around 80% of these pairing foods not individually associated with cardiometabolic traits, and food pairing pattern associations with cardiometabolic traits at hyper food group level were consistent across Eastern and Western populations. Besides, mediation analysis revealed that 72.7% of long-term food pairing patterns affected cardiometabolic traits through 31 microbial genera, with Clostridiumsensustricto1 playing a predominant role. Moreover, multi-step mediation analysis found that microbes mediated the impact of long-term food pairing patterns on cardiometabolic traits primarily through their metabolic pathways, such as pyruvate fermentation to propanoate and ergothioneine biosynthesis pathways. Our data suggest that balance between dietary foods is broadly associated with cardiometabolic traits by modulating gut microbial functionalities, in contrast to the lower occurrence when considering individual foods in isolation. These results offer a novel perspective for designing personalized dietary strategies beyond present dietary indices to enhance cardiometabolic health.

Year:

2025

Background: Human gut microbiome has complex relationships with the host, contributing to metabolism, immunity, and carcinogenesis. Methods: Summary-level data for gut microbiota and metabolites were obtained from MiBioGen, FINRISK and human metabolome consortia. Summary-level data for colorectal cancer were derived from a genome-wide association study meta-analysis. In forward Mendelian randomization (MR), we employed genetic instrumental variables (IV) for 24 gut microbiota taxa and six bacterial metabolites to examine their causal relationship with colorectal cancer. We also used a lenient threshold for nine apriori gut microbiota taxa as secondary analyses. In reverse MR, we explored association between genetic liability to colorectal neoplasia and abundance of microbiota studied above using 95, 19, and 7 IVs for colorectal cancer, adenoma, and polyps, respectively. Results: Forward MR did not find evidence indicating causal relationship between any of the gut microbiota taxa or six bacterial metabolites tested and colorectal cancer risk. However, reverse MR supported genetic liability to colorectal adenomas was causally related with increased abundance of two taxa: Gammaproteobacteria ( β = 0.027, which represents a 0.027 increase in log-transformed relative abundance values of Gammaproteobacteria for per one-unit increase in log OR of adenoma risk; P = 7.06×10 −8 ), Enterobacteriaceae ( β = 0.023, P = 1.29×10 −5 ). Conclusions: We find genetic liability to colorectal neoplasia may be associated with abundance of certain microbiota taxa. It is more likely that subset of colorectal cancer genetic liability variants changes gut biology by influencing both gut microbiota and colorectal cancer risk. Impact: This study highlights the need of future complementary studies to explore causal mechanisms linking both host genetic variation with gut microbiome and colorectal cancer susceptibility.

Year:

2025

The association between gut microbiota and physiological disorders underscores the crucial need to understand its largely unexplored biological functions. In this study, we analyzed 86,876 microbial proteins and 1,277 human proteins from 1,967 Chinese stool samples. Our results indicate that metaproteomic data captures the microbial biodiversity of a population more effectively than metagenomic data, displaying greater variability in microbial functions and providing reliable assessments of microbiota stability. We identified crucial functions of core microbes and discovered 10,714 associations between metaproteomic taxon, microbial function, or human proteins with 39 phenotypes, including 1,381 features related to Type 2 Diabetes (T2D). Importantly, Megasphaera elsdenii ’s conversion of lactate to butyric acid appears to lower blood glucose levels, suggesting a protective mechanism against T2D. Our study underscores the power of population-based metaproteomics to offer unique functional insights into the gut microbiota. Highlights - The first large-scale population-based metaproteomics landscape. - Metaproteomics efficiently maps microbial functions, exposing individual functional variation. - 10,714 associations between metaproteomic taxa, microbial functions, or human proteins with 39 phenotypes. - Megasphaera elsdenii protects against elevated blood glucose levels in the host by degrading lactate to produce butyric acid.

Year:

2024

Background: Human gut microbiome has complex relationships with the host, contributing to metabolism, immunity, and carcinogenesis. Methods: Summary-level data for gut microbiota and metabolites were obtained from MiBioGen, FINRISK and human metabolome consortia. Summary-level data for colorectal cancer were derived from a genome-wide association study meta-analysis. In forward Mendelian randomization (MR), we employed genetic instrumental variables (IV) for 24 gut microbiota taxa and six bacterial metabolites to examine their causal relationship with colorectal cancer. We also used a lenient threshold for nine apriori gut microbiota taxa as secondary analyses. In reverse MR, we explored association between genetic liability to colorectal neoplasia and abundance of microbiota studied above using 95, 19, and 7 IVs for colorectal cancer, adenoma, and polyps, respectively. Results: Forward MR did not find evidence indicating causal relationship between any of the gut microbiota taxa or six bacterial metabolites tested and colorectal cancer risk. However, reverse MR supported genetic liability to colorectal adenomas was causally related with increased abundance of two taxa: Gammaproteobacteria ( β = 0.027, which represents a 0.027 increase in log-transformed relative abundance values of Gammaproteobacteria for per one-unit increase in log OR of adenoma risk; P = 7.06×10 −8 ), Enterobacteriaceae ( β = 0.023, P = 1.29×10 −5 ). Conclusions: We find genetic liability to colorectal neoplasia may be associated with abundance of certain microbiota taxa. It is more likely that subset of colorectal cancer genetic liability variants changes gut biology by influencing both gut microbiota and colorectal cancer risk. Impact: This study highlights the need of future complementary studies to explore causal mechanisms linking both host genetic variation with gut microbiome and colorectal cancer susceptibility.

Year:

2024

Background: Human gut microbiome has complex relationships with the host, contributing to metabolism, immunity, and carcinogenesis. Methods: Summary-level data for gut microbiota and metabolites were obtained from MiBioGen, FINRISK and human metabolome consortia. Summary-level data for CRC were derived from a genome-wide association study meta-analysis. In forward MR, we employed genetic instrumental variables (IVs) for 24 gut microbiota taxa and six bacterial metabolites to examine their causal relationship with CRC. We also utilized a lenient threshold for nine apriori gut microbiota taxa as secondary analyses. In reverse MR, we explored association between genetic liability to colorectal neoplasia and abundance of microbiota studied above using 95, 19, and 7 IVs for CRC, adenoma, and polyps, respectively. Results: Forward MR didn’t find evidence indicating causal relationship between any of the gut microbiota taxa or six bacterial metabolites tested and CRC risk. However, reverse MR supported genetic liability to colorectal adenomas was causally related with increased abundance of two taxa: Gammaproteobacteria (β=0.027, which represents a 0.027 increase in log-transformed relative abundance values of Gammaproteobacteria for per one-unit increase in log odds ratio of adenoma risk; P=7.06×10-8), Enterobacteriaceae (β=0.023, P=1.29×10-5). Conclusions: We find genetic liability to colorectal neoplasia may be associated with abundance of certain microbiota taxa. It is more likely that subset of CRC genetic liability variants changes gut biology by influencing both gut microbiota and CRC risk. Impact: This study highlights the need of future complementary studies to explore causal mechanisms linking both host genetic variation with gut microbiome and CRC susceptibility.

Year:

2024

Background: Human gut microbiome has complex relationships with the host, contributing to metabolism, immunity, and carcinogenesis. Methods: Summary-level data for gut microbiota and metabolites were obtained from MiBioGen, FINRISK and human metabolome consortia. Summary-level data for colorectal cancer were derived from a genome-wide association study meta-analysis. In forward Mendelian randomization (MR), we employed genetic instrumental variables (IV) for 24 gut microbiota taxa and six bacterial metabolites to examine their causal relationship with colorectal cancer. We also used a lenient threshold for nine apriori gut microbiota taxa as secondary analyses. In reverse MR, we explored association between genetic liability to colorectal neoplasia and abundance of microbiota studied above using 95, 19, and 7 IVs for colorectal cancer, adenoma, and polyps, respectively. Results: Forward MR did not find evidence indicating causal relationship between any of the gut microbiota taxa or six bacterial metabolites tested and colorectal cancer risk. However, reverse MR supported genetic liability to colorectal adenomas was causally related with increased abundance of two taxa: Gammaproteobacteria ( β = 0.027, which represents a 0.027 increase in log-transformed relative abundance values of Gammaproteobacteria for per one-unit increase in log OR of adenoma risk; P = 7.06×10 −8 ), Enterobacteriaceae ( β = 0.023, P = 1.29×10 −5 ). Conclusions: We find genetic liability to colorectal neoplasia may be associated with abundance of certain microbiota taxa. It is more likely that subset of colorectal cancer genetic liability variants changes gut biology by influencing both gut microbiota and colorectal cancer risk. Impact: This study highlights the need of future complementary studies to explore causal mechanisms linking both host genetic variation with gut microbiome and colorectal cancer susceptibility.

Year:

2024

Year:

2024

Collaborators (8)

Richard Houlston

Professor

Institute of Cancer Research Sutton

UNITED KINGDOM
View details

Susanna Larsson

Professor at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Philip Law

Institute of Cancer Research

UNITED KINGDOM
View details

Ian Tomlinson

University of Edinburgh

UNITED KINGDOM
View details

Yuanqing Fu

Westlake University

CHINA
View details

Lijuan Wang

University of Cambridge

UNITED KINGDOM
View details

Shuai Yuan

Karolinska Institutet

SWEDEN
View details

Malcolm Dunlop

Professor

University of Edinburgh

UNITED KINGDOM
View details